Skills shortages could scupper Singapore's pharma growth prospects

20 May 2014
singapore

As increasing numbers of pharmaceutical companies expand into Singapore, future growth could be impacted by a marked skills shortage, according to the Global Sentiment Survey from Berkley Group.

The group, which analyzes employment and market perceptions, said that a people crisis looms for pharma companies in the country. Recent reports from the Ministry of Trade reveal that the Singapore economy grew 5.4% in first-quarter 2014, which has led to increased investment in the region and heightened confidence amongst jobseekers and employers. Despite this, Berkley’s research reveals that future growth may be halted by a lack of available talent. The report says that 80% of the current workforce intends to move jobs in the next year, with 60% planning to do so within six months.

Robust attraction and retention strategy a must for employers

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical